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The Antenatal Genetic Testing Program at
MCV began in 1973. The standard scheme for
antenatal genetic testing involves counseling.
the methods of carrier detection available, ul
trasound, amniocentesis, and laboratory evalu
ation. Patients are referred because of a family
or personal history of a genetic abnormality or
because they have been evaluated in a carrier
detection program like those for Tay-Sachs dis
ease or Sickle Cell disease and are known car
riers. After referral, patients are given genetic
counseling by me and members of the Depart
ment of Human Genetics; if antenatal genetic
testing is deemed appropriate, we obtain in
formed consent and proceed with an ultrasound
study. The primary reason for doing an ul
trasound study prior to amniocentesis is to de
tect twins. Twins are most likely to be in sepa
rate amniotic sacs and have different
karyotypes; therefore, fluid must be obtained
from each sac.
The indications for referral are listed in
Table 1. The most frequent is advanced mater
nal age, generally considered to be 35 years or
greater. If a mother is less than 35 years and
pregnant, she has a 0.2% risk of having a child
with Down Syndrome (about 1 in 600). Between
35 and 40 years of age the risk of having a
child with Down Syndrome is between 1% and
1 %% and between 40 and 45 years of age it is
about 2% or about a 5 to 10 times greater risk
than the general population.
Another common reason for ultrasound
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study is that the patient has had a previously
chromosomany abnormal child. The most com
mon abnormality is Trisomy 21 in which case
risk of the recurrence is 1 %. Occasionally, we
find that the proband has a translocation abnor
mality and that one of the parents is a balanced
carrier which results in a rate of recurrence of
from 20% to 100%. A significant family history
of chromosomally abnormal offspring (sister,
brother. and their children) may also be a clue
lo a translocation defect. Other indications for
studies include metabolic defects amenable to
prenatal detection and a previous child or
known carrier status for a sex-linked disease
(hemophilia or Duchenne muscular dystrophy).
The history of a previous child or close relative
with a neural tube defect (NTD) (either anence
phaly, encephalocele or meningomyelocele) is
a very common reason for referral_ Neural tube
defects have a genetic component, so that if a
couple has had an affected child, the risk of a
subsequent child with a NTD is 5%, and if there
have been two affected children, the risk is
10% for having a child with a NTD. Patients
with close relatives with a NTD have a 1% risk
of occurrence.
As mentioned, ultrasound is used primar
ily to diagnose twins. Once twins have been
ruled out ultrasound is very useful for locating a
pocket of amniotic fluid and measuring the
angle and depth at which the needle has to en
ter the sac to withdraw fluid. The Figure is an ul
trasound visualization of a uterus, with the fetus
inside, at about 14 weeks gestation. The chest
and head are easily identified, as is a thick ante
rior placenta. The amniotic fluid is the dark area
and the proper needle placement is indicated.
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TABLE 1
Indications for Referral for Antenatal Genetic Testing
I
2
3
4
5
6

Advanced malernal age (2: 35 years old)
Previous child with a chromosome abnormality
Parents who carry a transtocation gene
Previous child with an inborn error of metabolism
Previous child with a severe X-1,nked disease
Previous child or close retat,ve w,th a neural tube defect

Amniocentesis is the procedure by which
amniotic fluid is obtained through the abdomen
of the mother with a needle. (If we have prob
lems obtaining fluid we can use ultrasound in
con1unction with amniocentesis to see the tip of
the needle ) We use a disposable kit for amnio
centesis which has a 22-gauge spinal needle,
local anesthesia, and Betadine swabs, which
are used to prepare the abdomen after we have
decided where the needle is to be inserted. Af
ter draping the abdomen with a sterile towel, the
skin and subcutaneous tissue is anesthetized
and the needle is inserted. The needle has a
stylet which is then removed and an extension
tube attached without interrupting the flow of
fluid being withdrawn through the needle. Since
the most common laboratory evaluation from
the amniotic fluid is chromosome analysis, the
fluid is processed by the cytogenetic lab in the
Department of Human Genetics. It takes three
to four weeks to complete the analysis with a
range of about two and one half to six weeks.
The fetal karyotypes are obtained from cultured
fetal cells in the amniotic fluid obtained at 1 4 to
1 6 weeks gestation
Another fairly recent and exciting area in
the field of intrauterine diagnosis is that of fetal
structural defects. The first group successfully
diagnosed is Neural Tube Defects (NTD) with
the association of elevated amniotic fluid alpha
fetoprotein in pregnancies with a NTD. In 1972
Brock and Sutcliff' published a series of pa:

tients in whom they had measured the amnioti�
fluid alpha-fetoprotein and found that there was
clearly a significant difference between a group
affected with NTD and a normal control group.
The most accurate range of pregnancy to mea
sure alpha-fetoprotein is 1 4 to 1 8 weeks. The
diagnosis of anencephaly and large men
ingomyeloceles can also be made easily with
modern ultrasound techniques. Because men
ingomyeloceles and spina bifida are more diffi
cult to demonstrate by ultrasound, we rely
mainly on alpha-fetoprotein in the amniotic fluid
for their detection. In addition, with more so
phisticated ultrasound equipment, we are able
to diagnose other structural defects such as
dwarfism (by measuring fetal limb lengths) and
polycystic kidneys (Potter syndrome).
A number of questions are frequently
asked about this testing Could you accidentally
hit the baby with the needle? This has certainly
happened and has been reported in the litera
ture. I reviewed one series with an intracardiac
fetal puncture and death during an amniocen
tesis at 1 6 weeks. The recorded pregnancy loss
rate nationwide is about 1 % as a result of am
niocentesis. At MCV two pregnancies have
been lost in a series of 531 patients One pa
tient developed chorioamnionitis within 24
hours and one patient had ruptured membranes
about an hour after the procedure, giving a fetal
mortality of 0.4%. We have had no fetal punc-

TABLE 2
Results of Antenatal Genetic Testing
9-1-73 to 9-6-79
269
255
5

2

46XY (normal mate)
46XX (normal female)
46XX+21 and 46XY+21 (Trisomy 21)
45XO (Turner syndrome)
4 ?XX+ 18 (Trisomy 18)
45XY. I (18p 21 p)
46XX 46XXr(9) (mosaic)
45XX, I(14q,21q)
46XX. 45 XO (mosaic)
46XX. I (6p, l 4p)
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F,gure--Ultrasound visualization of a fetus in utero at 1 4
weeks gestation

tures. This 1s an acceptable mortality rate con
sillering that most of these patients have at least
a i1 % risk of having an abnormality and some
as high as 5%.
Another common question is, how much
does it cost to have the testing?2 The cost var
ies from center to center, but the range in Vir
ginia is $4 70 to $520. MCV charges $520
which includes genetic counseling, amniocen
tesis, ultrasound study and karyotype examina
tion. If the patient needs only the alpha-fetopro
tein determination, the cost is $1 75. The MCV
experience with antenatal genetic studies in
volves 531 patients, the majority of whom were
studied because of advanced maternal age.
The second most common indication was a pre-

v1ous cl11ld with a NTD and the third was a pre
vious child with Trisomy 21 The rest were a va
riety of indications; perhaps the most interesting
was one patient who demanded elective sex de
termination. The results of chromosome analy
sis from our patients are presented in Table 2.
Five fetuses were diagnosed as having Down
Syndrome, and of seven fetuses with abnormal
alpha-fetoprotein, all had a NTD. All abnormal
fetuses were aborted and the diagnosis con
firmed.
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